NCT05710328 2026-05-05Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT TrialEastern Cooperative Oncology GroupPhase 2 Active not recruiting235 enrolled